Consequently, in absence of orally administered CBM 588, GPR120 KO mice (Control (GPR120 KO) group) showed comparable results on viral burden in the lung tissue, IFN-λ2,3 production level, body weight loss due to virus infection, and survival ratio with wild type mice (Control group) (Figures 3B–3D). The gene discussed is IFNL2; the disease is viral infectious disease.